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Addition of platelet-derived growth factor (PDGF) to quiescent cultures of Swiss 3T3 fibroblasts rapidly 
increased the cytoplasmic free Ca*+ concentrations and afterwards the c-myc mRNA levels. The concentra- 
tions of PDGF needed for both reactions were roughly the same. Moreover, the Caz+ ionophores, A23187 
and ionomycin, mimicked the actions of PDGF and increased the c-myc mRNA levels. These results suggest 
that Caz+ may be involved in the regulation of PDGF-induced expression of the c-myc gene. 
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1. INTRODUCTION 
PDGF is one of the major mitogens found in 
serum. This growth factor makes fibroblasts leave 
the Go state of the cell cycle, and stimulates the 
cells to initiate DNA synthesis and subsequently, 
to divide in the presence of other growth factors 
such as epidermal growth factor and insulin [l-3]. 
Recently, it has been clarified that PDGF 
stimulates expression of the c-myc gene in Balb/c 
3T3 fibroblasts [4]. It has also been demonstrated 
that expression of c-myc from recombinant 
plasmids introduced into the cells by gene transfer 
eliminates partly the PDGF requirement for cell 
growth in this cell line [5]. These results strongly 
suggest that the c-myc gene may play a role of 
crucial importance in the mitogenic action of 
PDGF. However, the mode of action of PDGF in 
expression of this gene has not been clarified. It 
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Abbreviations: PDGF, platelet-derived growth factor; 
[Ca’+],, cytoplasmic free Ca2+ concentration; FCS, fetal 
calf serum 
has been shown that PDGF rapidly increases the 
levels of [Ca2’]i in Swiss 3T3 and human 
fibroblasts [6,7]. Ca2+ is generally considered to 
serve as a second messenger to various ex- 
tracellular signals [8]. Therefore, we have in- 
vestigated whether Ca2+ may be involved in 
PDGF-induced expression of the c-myc gene in 
Swiss 3T3 cells. 
2. MATERIALS AND METHODS 
2.1. Materials 
Swiss 3T3 cells, PDGF and pBR322 plasmids 
containing human c-myc gene were kindly supplied 
by Dr E. Rozengurt (Imperial Cancer Research 
Fund, England), Dr T.F. Deuel (Washington 
University School of Medicine, USA) and Dr J.M. 
Bishop (University of California, San Francisco), 
respectively. A23 187 and ionomycin were obtained 
from Calbiochem-Behring. Quin2 acetoxymethyl 
ester and Cytodex 1 microcarrier beads were from 
Dojindo Laboratories and Pharmacia Fine 
Chemicals, respectively. [a-32P]dATP was from 
Amersham. Other materials and chemicals were 
obtained from commercial sources. 
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2.2. Cell culture 
Stock cultures of Swiss 3T3 cells were main- 
tained in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% FCS, penicillin 
(100 units/ml) and streptomycin (100 pg/ml) in a 
humidified atmosphere of 10% CO*:90~0 air at 
37°C as described [9]. 
2.3. Measurement of [Cd’], 
The levels of [Ca’+]i were measured according to 
Morris et al. [lo]. Briefly, cells were seeded at a 
density of 5 x lo4 cells/ml onto Cytodex 1 
microcarrier beads at 2 mg/ml, grown to con- 
fluence in DMEM containing 10% FCS stirred 
continuously at 25 rpm, refed with the same 
medium after 2 days, and used 5 days after the last 
change of medium. Cells attached to beads were 
washed by centrifugation in serum-free DMEM 
supplemented with 10 mM Hepes, 20 mM 
NaHCOs and gassed with 10% COz at pH 7.2. 
Then, the cells were incubated with the same 
medium containing 10 PM quin2 acetoxymethyl 
ester for 45 min at 37°C in a humidified at- 
mosphere of 10% COz: 90% air. The cells were 
washed twice by centrifugation in Hepes-buffered 
saline (10 mM Hepes at pH 7.4 containing 
145 mM NaCl, 5 mM KCl, 1 mM MgS04,0.5 mM 
Na2HP04, 1 mM CaCl2 and 5 mM glucose). In- 
tracellular quin2 fluorescence (excitation 339 nm, 
emission 492 nm) was measured in a Shimadzu 
model RF-5 1 OLC fluorescence spectromonitor 
with constant stirring at 37°C. Values of [CaZf], 
were calculated from fluorescence signals as 
described by Tsien et al. [l 11. 
2.4. Assay for c-myc mRNA 
For analysis of c-myc mRNA, the cells were 
seeded at a density of 1.5 x lo5 cells in 100-mm 
dishes with 15 ml of DMEM containing 10% FCS, 
refed with the same medium after 2 days, and used 
at least 5 days after the last change of medium. The 
cultures were washed twice with DMEM at 37°C 
and then incubated for 3 h with various concentra- 
tions of stimuli. The reaction was stopped by chill- 
ing the dishes on ice and the cells were scraped off. 
Total RNA of the cells was extracted by the pro- 
cedure of Chirgwin et al. [12] utilizing the CsCl 
gradient centrifugation. For dot blot analysis, 
RNA samples were dotted onto nitrocellulose 
filters under a low vacuum. After baking, the 
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filters were hybridized for 48 h at 42°C with 32P- 
labeled DNA probe, and the unbound fraction was 
removed by extensive washing. The filters were 
autoradiographed using an intensifying screen for 
24 h at -70°C, and the dots were excised and 
counted in a scintillation counter. The “P-labeled 
DNA probe used was the C/aI-EcoRI fragment of 
the normal human c-myc gene (including most of 
the 3’-exon) labeled by the random-primer method 
[13,14]. 
3. RESULTS AND DISCUSSION 
When quiescent cultures of Swiss 3T3 
fibroblasts were incubated with PDGF, there was 
an immediate increase of [Ca2’],. Typical increases 
of [Ca’+]i in response to various amounts of 
PDGF are shown in fig.1. The basal level of 
[Ca”], was 112-148 nM (mean it SE, 130 f 5 nM; 
n = 12). On addition of 50 ng/ml of PDGF, 
[Ca’+]i increased to more than 300 nM within 
2 min. After this rapid rise in [Ca’+],, the c-myc 
mRNA levels had increased markedly (fig.2). The 
increase of c-myc mRNA levels by PDGF was 
dose-dependent (fig.3), and the amounts of this 
growth factor needed for this reaction were nearly 
the same as those needed for the increase of 
[Ca2+]i. Furthermore, the Ca2” ionophores such as 
A23187 and ionomycin were able to substitute for 
PDGF and increased the c-myc mRNA levets (figs 
ICc?+l, 
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Fig.1. PDGF-induced increase of [Ca”],. Swiss 3T3 
cells attached onto Cytodex 1 microcarrier beads were 
loaded with quin2 and stimulated by various amounts of 
PDGF in Hepes-buffered saline containing 1 mM 
CaC12. With: (A) 50 ng/ml of PDGF, (B) 25 ng/ml of 
PDGF, (C) 12.5 ng/ml of PDGF. Arrows indicate the 
points of PDGF addition. 
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Fig.2. Dot blot analysis of c-myc mRNA levels after 
incubation with PDGF, A23187 and ionomycin. 
Quiescent cultures of Swiss 3T3 cells were incubated for 
3 h with PDGF (50 ng/ml), A23187 (1.2pM) or 
ionomycin (1.2 FM). (A) No addition, (B) with PDGF, 
(C) with A23187, (D) with ionomycin. (a) 2pg total 
RNA, (b) 4 ,@ total RNA, (c) 8 pg of total RNA. 
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Fig.3. Dose-dependent increase of c-myc mRNA levels 
induced by PDGF, A23187 and ionomycin. Quiescent 
cultures of Swiss 3T3 cells were incubated for 3 h with 
various amounts of PDGF, A23187 or ionomycin as 
indicated. The levels of c-myc mRNA are expressed as 
cpmMpg total RNA. Each value is the mean of 
triplicate determinations. With: (A) PDGF, (B) A23187, 
(C) ionomycin. 
2 and 3). The maximum levels of this mRNA in- 
duced by these ionophores were roughly equal to 
those induced by PDGF. It has been reported that 
PDGF-induced elevation of c-myc mRNA levels is 
Table 1 
Effect of cycloheximide on PDGF- and A23187-induced 
increase of c-myc mRNA levels 
Additions c-myc mRNA (cpm) 
Cycloheximide Cycloheximide 
(-) (+) 
None 30 170 
PDGF 250 400 
A23187 190 320 
Quiescent cultures of Swiss 3T3 cells were incubated for 
3 h with various additions as indicated. PDGF 
(62.5 ng/ml), A23187 (1.2 PM) and cycloheximide 
(lOpg/ml) were employed. The levels of c-myc mRNA 
are expressed as cpm/4 pg total RNA. Each value is the 
mean of triplicate determinations 
further enhanced by the addition of cyclohex- 
imide, which by itself increases the levels of c-myc 
mRNA [4]. The A23 187-induced increase of c-myc 
mRNA levels was also further enhanced by the ad- 
dition of this compound as shown in table 1, sug- 
gesting that expression of the c-myc gene by 
A23187 as well as by PDGF does not require the 
synthesis of new proteins. 
The results presented above clearly indicate that 
PDGF induces both Ca*+ mobilization and c-myc 
gene expression in Swiss 3T3 cells. Moreover, 
evidence is presented that expression of the c-myc 
gene is stimulated by the Ca*+ ionophores. These 
results strongly suggest hat Ca2+ may serve as a 
messenger for PDGF-induced expression of the c- 
myc gene. PDGF has been shown to stimulate 
phosphoinositide turnover to produce inositol 
trisphosphate, which then mobilizes Ca*+ from in- 
tracellular stores to the cytoplasm [6]. Therefore, 
it is likely that the cytoplasmic free Ca*+ mobilized 
in this way may be responsible for the activation of 
this gene. It is generally accepted that the diverse 
effects of Ca*+ may be mediated through the ac- 
tivation of calmodulin, a ubiquitous Ca*+-receptor 
protein [ 151. The involvement of calmodulin in the 
c-myc gene activation is now under investigation. 
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